Amgen (NASDAQ:AMGN) executives outlined the company’s oncology research and development priorities and provided updates on ...

This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...

Adults with obesity may now move directly from Wegovy 2.4mg to 7.2mg if they need greater weight loss ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Hims & Hers Health, Inc. faces volatile earnings as compounded GLP-1 setbacks pressure shares. Click for this HIMS stock earnings preview.

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...

A new overview details emerging medical and wellness trends, underscoring advances that broaden treatment access and inform preventive care. GLP-1 drugs such as Ozempic and Wegovy extend to heart, ...

My son is smart - he really is - but he was in love. He and his live-in girlfriend mingled their finances. I'm not sure how much, but now that they've parted, his credit rating is wrecked. Just enough ...

A new study confirms that people taking GLP-1s are more likely to experience hair loss. The good news? It’s probably reversible. Here’s how to deal.

A new review finds no convincing evidence that drugs like Ozempic raise people's risk of common thyroid cancers.

In an interview with The American Journal of Managed Care®, Levin explained that for patients whose medications are covered ...

At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a program offering surgical interventions to treat obesity. One in three Philadelphians are living ...